Company
Innocoll
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Using a proprietary collagen-based technology, Innocoll is developing a portfolio of products to treat post-operative pain and prevent post-surgical adhesions. Innocoll was listed on NASDAQ as INNL prior to its acquisition by Gurnet Point in 2017
Loading relationship preview